1. Home
  2. YMAT vs MDAI Comparison

YMAT vs MDAI Comparison

Compare YMAT & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAT
  • MDAI
  • Stock Information
  • Founded
  • YMAT 1970
  • MDAI 2013
  • Country
  • YMAT Taiwan
  • MDAI United States
  • Employees
  • YMAT N/A
  • MDAI N/A
  • Industry
  • YMAT Recreational Games/Products/Toys
  • MDAI Medical/Dental Instruments
  • Sector
  • YMAT Consumer Discretionary
  • MDAI Health Care
  • Exchange
  • YMAT Nasdaq
  • MDAI Nasdaq
  • Market Cap
  • YMAT 76.4M
  • MDAI 69.0M
  • IPO Year
  • YMAT 2025
  • MDAI N/A
  • Fundamental
  • Price
  • YMAT $5.59
  • MDAI $2.09
  • Analyst Decision
  • YMAT
  • MDAI Strong Buy
  • Analyst Count
  • YMAT 0
  • MDAI 1
  • Target Price
  • YMAT N/A
  • MDAI $3.50
  • AVG Volume (30 Days)
  • YMAT 808.5K
  • MDAI 379.5K
  • Earning Date
  • YMAT 01-01-0001
  • MDAI 08-12-2025
  • Dividend Yield
  • YMAT N/A
  • MDAI N/A
  • EPS Growth
  • YMAT N/A
  • MDAI N/A
  • EPS
  • YMAT 0.07
  • MDAI N/A
  • Revenue
  • YMAT $17,563,985.00
  • MDAI $27,549,000.00
  • Revenue This Year
  • YMAT N/A
  • MDAI N/A
  • Revenue Next Year
  • YMAT N/A
  • MDAI $15.15
  • P/E Ratio
  • YMAT $79.80
  • MDAI N/A
  • Revenue Growth
  • YMAT N/A
  • MDAI 22.27
  • 52 Week Low
  • YMAT $3.80
  • MDAI $0.82
  • 52 Week High
  • YMAT $6.45
  • MDAI $3.25
  • Technical
  • Relative Strength Index (RSI)
  • YMAT N/A
  • MDAI 39.51
  • Support Level
  • YMAT N/A
  • MDAI $1.98
  • Resistance Level
  • YMAT N/A
  • MDAI $2.24
  • Average True Range (ATR)
  • YMAT 0.00
  • MDAI 0.15
  • MACD
  • YMAT 0.00
  • MDAI -0.03
  • Stochastic Oscillator
  • YMAT 0.00
  • MDAI 19.30

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: